May 5, 2014

Teva Pharmaceutical Industries on Monday announced that the Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) for injection, to include home administration.

February 13, 2014

Teva Pharmaceutical Industries announced that the Food and Drug Administration has granted full approval of Synribo (omacetaxine mepesuccinate) for injection.

December 23, 2013

The Food and Drug Administration has approved revisions to the labeling of a leukemia drug made by Ariad Pharmaceuticals that allow the company to resume selling it, the company said.

December 14, 2012

The Food and Drug Administration has approved a new leukemia drug made by Ariad Pharmaceuticals, the agency said.

October 26, 2012

The Food and Drug Administration has approved what it called the second new drug in two months for a form of leukemia, the agency said Friday.

September 5, 2012

The Food and Drug Administration has approved a new drug for treating a rare blood and marrow cancer that affects older adults, the agency said Tuesday.

October 27, 2010

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

July 11, 2010

A cancer drug made by Bristol-Myers Squibb and Otsuka Pharmaceutical has received priority review from...

June 17, 2010

The Food and Drug Administration has approved a drug as an early treatment for a...

February 18, 2010

The Food and Drug Administration will shorten its review time of a Novartis drug under...